GeneDx Holdings Corp. (WGS)
68.53
-2.99
(-4.18%)
USD |
NASDAQ |
Oct 07, 16:00
68.48
-0.05
(-0.07%)
After-Hours: 20:00
GeneDx Holdings Net Income (Quarterly) : -17.74M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -17.74M |
| March 31, 2026 | -63.32M |
| December 31, 2025 | -17.67M |
| September 30, 2025 | -7.635M |
| June 30, 2025 | 10.81M |
| March 31, 2025 | -6.529M |
| December 31, 2024 | 5.438M |
| September 30, 2024 | -8.312M |
| June 30, 2024 | -29.17M |
| March 31, 2024 | -20.24M |
| December 31, 2023 | -25.77M |
| September 30, 2023 | -42.29M |
| Date | Value |
|---|---|
| June 30, 2023 | -46.72M |
| March 31, 2023 | -60.99M |
| December 31, 2022 | -308.76M |
| September 30, 2022 | -77.58M |
| June 30, 2022 | -85.74M |
| March 31, 2022 | -76.90M |
| December 31, 2021 | -40.18M |
| September 30, 2021 | 32.73M |
| June 30, 2021 | -46.16M |
| March 31, 2021 | -191.78M |
| December 31, 2020 | -125.68M |
| September 30, 2020 | -56.62M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Twist Bioscience Corp. | -35.05M |
| CS Diagnostics Corp. | 0.0391M |
| Aibotics, Inc. | -0.537M |
| Intellia Therapeutics, Inc. | -106.63M |
| 10X Genomics, Inc. | -17.93M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 114.44M |
| Total Expenses (Quarterly) | 132.18M |
| EPS Diluted (Quarterly) | -0.5971 |
| Enterprise Value | 2.077B |
| Gross Profit Margin (Quarterly) | 64.05% |
| Profit Margin (Quarterly) | -15.50% |
| Earnings Yield | -5.30% |
| Normalized Earnings Yield | -3.801 |